Cargando…
Multi-omics for COVID-19: driving development of therapeutics and vaccines
The ongoing COVID-19 pandemic caused by SARS-CoV-2 has raised global concern for public health and economy. The development of therapeutics and vaccines to combat this virus is continuously progressing. Multi-omics approaches, including genomics, transcriptomics, proteomics, metabolomics, epigenomic...
Autores principales: | Guo, Mengyu, Xiong, Muya, Peng, Jinying, Guan, Tong, Su, Haixia, Huang, Yanyi, Yang, Cai-Guang, Li, Yang, Boraschi, Diana, Pillaiyar, Thanigaimalai, Wang, Guanbo, Yi, Chengqi, Xu, Yechun, Chen, Chunying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627145/ https://www.ncbi.nlm.nih.gov/pubmed/37936830 http://dx.doi.org/10.1093/nsr/nwad161 |
Ejemplares similares
-
Advances in single-cell multi-omics profiling
por: Bai, Dongsheng, et al.
Publicado: (2021) -
Discovery of Polyphenolic Natural Products as SARS-CoV-2 M(pro) Inhibitors for COVID-19
por: Krüger, Nadine, et al.
Publicado: (2023) -
Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2017) -
Recent discovery and development of inhibitors targeting coronaviruses
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020) -
Reaction of indoles with aromatic fluoromethyl ketones: an efficient synthesis of trifluoromethyl(indolyl)phenylmethanols using K(2)CO(3)/n-Bu(4)PBr in water
por: Pillaiyar, Thanigaimalai, et al.
Publicado: (2020)